Arthur Straughn Email

Co-founder Board Directors . Cingulate

Current Roles

Employees:
18
Revenue:
$0
About
Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. \n \nWe aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. \n \nWith an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.
Cingulate Address

Kansas City, KS
United States
Cingulate Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.